secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0000950170-24-071953
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MindMed shareholders elect directors, approve auditor and employee share purchase plan
--------------------------------------------------------------------------------

- Six director nominees elected with votes for ranging from 18.1M to 23.7M; broker non-votes 13.8M.
- Appointment of KPMG LLP as auditor approved: 36.8M for, 0.8M withheld.
- 2024 Employee Share Purchase Plan approved: 23.4M for, 0.3M against, 0.2M abstain, 13.8M broker non-votes.
- Quorum of 37.6M shares (52.4% of 71.9M outstanding) present at June 10 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017024071953/0000950170-24-071953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017024071953/mnmd-20240610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer